checkAd

     399  0 Kommentare Georgia's $14 Million Bioscience Training Center an Offshoot of Baxter's $1 Billion Plant, an Industrial Info News Alert

    SUGAR LAND, TX--(Marketwired - Apr 17, 2014) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- It was a definite win for Georgia's burgeoning bioscience sector when Baxter International Corporation (NYSE:BAX) (Deerfield, Illinois) decided to invest $1 billion to construct a 1 million-square-foot plasma fractionation facility with purification and fill/finish suites in Covington, Georgia. In support of the massive project, now under construction, the state is building the $14 million Georgia BioScience Training Center adjacent to the new plant.

    For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/news/abstract.jsp?newsitemID=241686&refer=mw, or browse other breaking industrial news stories at www.industrialinfo.com.

    Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.

    Contact:
    Joe Govreau
    713-783-5147




    Diskutieren Sie über die enthaltenen Werte




    Verfasst von Marketwired
    Georgia's $14 Million Bioscience Training Center an Offshoot of Baxter's $1 Billion Plant, an Industrial Info News Alert SUGAR LAND, TX--(Marketwired - Apr 17, 2014) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- It was a definite win for Georgia's burgeoning bioscience sector when Baxter International Corporation (NYSE:BAX) …

    Schreibe Deinen Kommentar

    Disclaimer